Marksans Pharma informs about opening of special window

11 Mar 2026 Evaluate

In order to facilitate ease of investing for investors and to secure their rights in the securities purchased by them, Securities and Exchange Board of India, vide its Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, Marksans Pharma has informed that it has extended a special window to facilitate re-lodgment of transfer deeds that were lodged with respect to shares purchased/sold prior to April 1, 2019 but were rejected, returned or not attended to due to deficiencies in transfer documents or other reasons. In connection with the above matter, it has enclosed a public notice for information of shareholders of the Company.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

172.95 -1.05 (-0.60%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×